EPRX (eupraxiapharma.com) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals (EPRX) is developing innovative methods for prolonging drug action. The absence of commercialized products and a focus on delivery system testing make scaling impossible, while research expenditures result in losses. The stock price history reflects the P/E ratio dynamics, which currently stands at 0.00. The company's prospects rely on the success of the EP-104 drug for osteoarthritis and the implementation of its platform within the oncology sphere.

Eupraxia Pharmaceuticals - Rasio kapitalisasi marang bathi mangsa ngarep EPRX (periode 06.04.2024 - 17.11.2026)

Ringkesan rincian data analitis eupraxiapharma.com (EPRX)

Pambiji fundamental:Eupraxia Pharmaceuticals Inc.
Produk merek Eupraxia Pharmaceuticals

Forward P/E measures the market premium for expected net income growth, determining the cost of a single unit of projected earnings. An investor compares this ratio with the fundamental stability of assets to assess whether an asset is overbought. The forward P/E history of Eupraxia Pharmaceuticals (EPRX) visualizes the trend of the stock's attractiveness to institutional capital. For Eupraxia Pharmaceuticals (EPRX), this metric reflects the market's confidence in the monetization of its patented extended-release technologies. High barriers to entry in biopharmaceuticals justify long-term profit expectations.

Pesaing Eupraxia Pharmaceuticals (EPRX)

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SXTC|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP